No-one is claiming that new treatments for disease are a bad thing, but there are people who are seriously worried whether all of society will reap the greatest benefit possible from biology's crowning achievement.

If the agenda is set by short-term commercial goals, it could be a recipe for a nightmare

Dr Sue Meyer, Genewatch UK

Many ask who will own humanity's code for life and whether its exploitation will be for private profit or public health.

For Ethics of the Genome: Who owns it?click here.

Others are concerned about the ethical implications of being able to read your biological blueprint, with all its possible predictions.

For Ethics of the Genome: Moralityclick here.

Still more are asking whether employers or the insurance industry will harness gene testing to the detriment of a genetic underclass.

For Ethics of the Genome: Employment and insuranceclick here.